Gilead Sciences Total Liabilities and Share Holders Equity 2010-2024 | GILD

Gilead Sciences total liabilities and share holders equity for the quarter ending December 31, 2024 was $58.995B, a 5.04% decline year-over-year.

  • Gilead Sciences total liabilities and share holders equity for 2024 was $58.995B, a 5.04% decline from 2023.
  • Gilead Sciences total liabilities and share holders equity for 2023 was $62.125B, a 1.66% decline from 2022.
  • Gilead Sciences total liabilities and share holders equity for 2022 was $63.171B, a 7.04% decline from 2021.

Gilead Sciences Total Liabilities and Share Holders Equity 2010-2024 | GILD

  • Gilead Sciences total liabilities and share holders equity for 2024 was $58.995B, a 5.04% decline from 2023.
  • Gilead Sciences total liabilities and share holders equity for 2023 was $62.125B, a 1.66% decline from 2022.
  • Gilead Sciences total liabilities and share holders equity for 2022 was $63.171B, a 7.04% decline from 2021.